Global Pillcam Market

Pillcam Comprehensive Study by Type (Small Bowel, Esophageal, Colon), Category (Wireless Capsule, Workstation and Receiver), Indication (OGIB (Obscure Gastrointestinal Bleeding), Crohn’s Disease, Small Intestine Tumor, Others (Celiac Disease, NSAID Reactions)) Players and Region - Global Market Outlook to 2027

Pillcam Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Pillcam?
Pill Camera (Endoscopy Capsule) is a technology that allows medical professionals, particularly general physicians and gastroenterologists, to examine and re-examine the intestine for possible bleeding or infection. It is made of sealed biocompatible material that can withstand acid, enzymes, and other antibody chemicals in the stomach. Colonoscopy was the local way before to the invention of the Pill camera (Endoscopy Capsule), however research has shown that some areas of the intestine (bowel) cannot be reached by traditional methods, necessitating the use of the Pill Camera. Countless fatalities from stomach ailments such as polyps, inflammatory bowel disease (Crohn's disease), cancers, ulcers, anaemia, and small intestine tumours, which would normally be discovered by advanced equipment such as the Pill Camera, have become the norm in underdeveloped nations. AMA Research have also released a dedicated research coverage on Capsule Endoscopy System Market Share & Industry Growth Analysis.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledOlympus Corporation (Japan), IntroMedic Co., Ltd. (South Korea), Medtronic plc (Ireland), Chongqing Jinshan Science & Technology (Group) Co., Ltd (China), Fujifilm Holding Corporation (Japan), CapsoVision (United States), RF System lab (Japan) and Teleflex Incorporated (United States)


The study covers a detailed analysis segmented by key business segments i.e. by type (Small Bowel, Esophageal and Colon) and major geographies. Research Analyst at AMA predicts that United States & Japanese Players will contribute to the maximum growth of Global Pillcam market throughout the predicted period.

The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this Pillcam market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.

The report offers several leading Players, some of them are Olympus Corporation (Japan), IntroMedic Co., Ltd. (South Korea), Medtronic plc (Ireland), Chongqing Jinshan Science & Technology (Group) Co., Ltd (China), Fujifilm Holding Corporation (Japan), CapsoVision (United States), RF System lab (Japan) and Teleflex Incorporated (United States).

The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth.

Pillcam Market Dynamics:
AttributesDetails
Growth Drivers
  • Prevalence of Intestinal Diseases
  • High Investments in Healthcare R&D
Major Trends
  • Rising Geriatric Population
Restraints
  • Lack of Skilled Professionals
  • Accidental Concerns
Road Blocks / Challenges
  • Technological Limitations
Gaps & Opportunities
  • Growth in Healthcare Infrastructure Across Emerging Regions


Key highlights of the Global Pillcam market Study:
• CAGR of the market during the forecast period 2021-2027
• In-depth information on growth factors that will accelerate the Pillcam market in next few years.
• Detailed Insights on futuristic trends and changing consumer behavior
• Forecast of the Global Pillcam market size and its contribution to the parent market by type, application and by country.
• A broad view of customer demand
• Uncover market’s competitive landscape and in-depth information on various Players
• Comprehensive information about factors that will challenge the growth of Pillcam Players

Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
• A tipping point in globalization
• A major slowdown in Western economies
• Significant shifts in technology and cost structure
• The challenges of regulatory compliance
• New forms of competition developing

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Pillcam market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Pillcam market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Pillcam Manufactures, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.

Report Objectives / Segmentation Covered

By Type
  • Small Bowel
  • Esophageal
  • Colon
By Category
  • Wireless Capsule
  • Workstation and Receiver

By Indication
  • OGIB (Obscure Gastrointestinal Bleeding)
  • Crohn’s Disease
  • Small Intestine Tumor
  • Others (Celiac Disease, NSAID Reactions)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevalence of Intestinal Diseases
      • 3.2.2. High Investments in Healthcare R&D
    • 3.3. Market Challenges
      • 3.3.1. Technological Limitations
    • 3.4. Market Trends
      • 3.4.1. Rising Geriatric Population
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pillcam, by Type, Category, Indication and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Pillcam (Value)
      • 5.2.1. Global Pillcam by: Type (Value)
        • 5.2.1.1. Small Bowel
        • 5.2.1.2. Esophageal
        • 5.2.1.3. Colon
      • 5.2.2. Global Pillcam by: Category (Value)
        • 5.2.2.1. Wireless Capsule
        • 5.2.2.2. Workstation and Receiver
      • 5.2.3. Global Pillcam by: Indication (Value)
        • 5.2.3.1. OGIB (Obscure Gastrointestinal Bleeding)
        • 5.2.3.2. Crohn’s Disease
        • 5.2.3.3. Small Intestine Tumor
        • 5.2.3.4. Others (Celiac Disease, NSAID Reactions)
      • 5.2.4. Global Pillcam Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Pillcam: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Olympus Corporation (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. IntroMedic Co., Ltd. (South Korea)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtronic plc (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Chongqing Jinshan Science & Technology (Group) Co., Ltd (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Fujifilm Holding Corporation (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. CapsoVision (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. RF System lab (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Teleflex Incorporated (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Pillcam Sale, by Type, Category, Indication and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Pillcam (Value)
      • 7.2.1. Global Pillcam by: Type (Value)
        • 7.2.1.1. Small Bowel
        • 7.2.1.2. Esophageal
        • 7.2.1.3. Colon
      • 7.2.2. Global Pillcam by: Category (Value)
        • 7.2.2.1. Wireless Capsule
        • 7.2.2.2. Workstation and Receiver
      • 7.2.3. Global Pillcam by: Indication (Value)
        • 7.2.3.1. OGIB (Obscure Gastrointestinal Bleeding)
        • 7.2.3.2. Crohn’s Disease
        • 7.2.3.3. Small Intestine Tumor
        • 7.2.3.4. Others (Celiac Disease, NSAID Reactions)
      • 7.2.4. Global Pillcam Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pillcam: by Type(USD Million)
  • Table 2. Pillcam Small Bowel , by Region USD Million (2016-2021)
  • Table 3. Pillcam Esophageal , by Region USD Million (2016-2021)
  • Table 4. Pillcam Colon , by Region USD Million (2016-2021)
  • Table 5. Pillcam: by Category(USD Million)
  • Table 6. Pillcam Wireless Capsule , by Region USD Million (2016-2021)
  • Table 7. Pillcam Workstation and Receiver , by Region USD Million (2016-2021)
  • Table 8. Pillcam: by Indication(USD Million)
  • Table 9. Pillcam OGIB (Obscure Gastrointestinal Bleeding) , by Region USD Million (2016-2021)
  • Table 10. Pillcam Crohn’s Disease , by Region USD Million (2016-2021)
  • Table 11. Pillcam Small Intestine Tumor , by Region USD Million (2016-2021)
  • Table 12. Pillcam Others (Celiac Disease, NSAID Reactions) , by Region USD Million (2016-2021)
  • Table 13. South America Pillcam, by Country USD Million (2016-2021)
  • Table 14. South America Pillcam, by Type USD Million (2016-2021)
  • Table 15. South America Pillcam, by Category USD Million (2016-2021)
  • Table 16. South America Pillcam, by Indication USD Million (2016-2021)
  • Table 17. Brazil Pillcam, by Type USD Million (2016-2021)
  • Table 18. Brazil Pillcam, by Category USD Million (2016-2021)
  • Table 19. Brazil Pillcam, by Indication USD Million (2016-2021)
  • Table 20. Argentina Pillcam, by Type USD Million (2016-2021)
  • Table 21. Argentina Pillcam, by Category USD Million (2016-2021)
  • Table 22. Argentina Pillcam, by Indication USD Million (2016-2021)
  • Table 23. Rest of South America Pillcam, by Type USD Million (2016-2021)
  • Table 24. Rest of South America Pillcam, by Category USD Million (2016-2021)
  • Table 25. Rest of South America Pillcam, by Indication USD Million (2016-2021)
  • Table 26. Asia Pacific Pillcam, by Country USD Million (2016-2021)
  • Table 27. Asia Pacific Pillcam, by Type USD Million (2016-2021)
  • Table 28. Asia Pacific Pillcam, by Category USD Million (2016-2021)
  • Table 29. Asia Pacific Pillcam, by Indication USD Million (2016-2021)
  • Table 30. China Pillcam, by Type USD Million (2016-2021)
  • Table 31. China Pillcam, by Category USD Million (2016-2021)
  • Table 32. China Pillcam, by Indication USD Million (2016-2021)
  • Table 33. Japan Pillcam, by Type USD Million (2016-2021)
  • Table 34. Japan Pillcam, by Category USD Million (2016-2021)
  • Table 35. Japan Pillcam, by Indication USD Million (2016-2021)
  • Table 36. India Pillcam, by Type USD Million (2016-2021)
  • Table 37. India Pillcam, by Category USD Million (2016-2021)
  • Table 38. India Pillcam, by Indication USD Million (2016-2021)
  • Table 39. South Korea Pillcam, by Type USD Million (2016-2021)
  • Table 40. South Korea Pillcam, by Category USD Million (2016-2021)
  • Table 41. South Korea Pillcam, by Indication USD Million (2016-2021)
  • Table 42. Taiwan Pillcam, by Type USD Million (2016-2021)
  • Table 43. Taiwan Pillcam, by Category USD Million (2016-2021)
  • Table 44. Taiwan Pillcam, by Indication USD Million (2016-2021)
  • Table 45. Australia Pillcam, by Type USD Million (2016-2021)
  • Table 46. Australia Pillcam, by Category USD Million (2016-2021)
  • Table 47. Australia Pillcam, by Indication USD Million (2016-2021)
  • Table 48. Rest of Asia-Pacific Pillcam, by Type USD Million (2016-2021)
  • Table 49. Rest of Asia-Pacific Pillcam, by Category USD Million (2016-2021)
  • Table 50. Rest of Asia-Pacific Pillcam, by Indication USD Million (2016-2021)
  • Table 51. Europe Pillcam, by Country USD Million (2016-2021)
  • Table 52. Europe Pillcam, by Type USD Million (2016-2021)
  • Table 53. Europe Pillcam, by Category USD Million (2016-2021)
  • Table 54. Europe Pillcam, by Indication USD Million (2016-2021)
  • Table 55. Germany Pillcam, by Type USD Million (2016-2021)
  • Table 56. Germany Pillcam, by Category USD Million (2016-2021)
  • Table 57. Germany Pillcam, by Indication USD Million (2016-2021)
  • Table 58. France Pillcam, by Type USD Million (2016-2021)
  • Table 59. France Pillcam, by Category USD Million (2016-2021)
  • Table 60. France Pillcam, by Indication USD Million (2016-2021)
  • Table 61. Italy Pillcam, by Type USD Million (2016-2021)
  • Table 62. Italy Pillcam, by Category USD Million (2016-2021)
  • Table 63. Italy Pillcam, by Indication USD Million (2016-2021)
  • Table 64. United Kingdom Pillcam, by Type USD Million (2016-2021)
  • Table 65. United Kingdom Pillcam, by Category USD Million (2016-2021)
  • Table 66. United Kingdom Pillcam, by Indication USD Million (2016-2021)
  • Table 67. Netherlands Pillcam, by Type USD Million (2016-2021)
  • Table 68. Netherlands Pillcam, by Category USD Million (2016-2021)
  • Table 69. Netherlands Pillcam, by Indication USD Million (2016-2021)
  • Table 70. Rest of Europe Pillcam, by Type USD Million (2016-2021)
  • Table 71. Rest of Europe Pillcam, by Category USD Million (2016-2021)
  • Table 72. Rest of Europe Pillcam, by Indication USD Million (2016-2021)
  • Table 73. MEA Pillcam, by Country USD Million (2016-2021)
  • Table 74. MEA Pillcam, by Type USD Million (2016-2021)
  • Table 75. MEA Pillcam, by Category USD Million (2016-2021)
  • Table 76. MEA Pillcam, by Indication USD Million (2016-2021)
  • Table 77. Middle East Pillcam, by Type USD Million (2016-2021)
  • Table 78. Middle East Pillcam, by Category USD Million (2016-2021)
  • Table 79. Middle East Pillcam, by Indication USD Million (2016-2021)
  • Table 80. Africa Pillcam, by Type USD Million (2016-2021)
  • Table 81. Africa Pillcam, by Category USD Million (2016-2021)
  • Table 82. Africa Pillcam, by Indication USD Million (2016-2021)
  • Table 83. North America Pillcam, by Country USD Million (2016-2021)
  • Table 84. North America Pillcam, by Type USD Million (2016-2021)
  • Table 85. North America Pillcam, by Category USD Million (2016-2021)
  • Table 86. North America Pillcam, by Indication USD Million (2016-2021)
  • Table 87. United States Pillcam, by Type USD Million (2016-2021)
  • Table 88. United States Pillcam, by Category USD Million (2016-2021)
  • Table 89. United States Pillcam, by Indication USD Million (2016-2021)
  • Table 90. Canada Pillcam, by Type USD Million (2016-2021)
  • Table 91. Canada Pillcam, by Category USD Million (2016-2021)
  • Table 92. Canada Pillcam, by Indication USD Million (2016-2021)
  • Table 93. Mexico Pillcam, by Type USD Million (2016-2021)
  • Table 94. Mexico Pillcam, by Category USD Million (2016-2021)
  • Table 95. Mexico Pillcam, by Indication USD Million (2016-2021)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Pillcam: by Type(USD Million)
  • Table 105. Pillcam Small Bowel , by Region USD Million (2022-2027)
  • Table 106. Pillcam Esophageal , by Region USD Million (2022-2027)
  • Table 107. Pillcam Colon , by Region USD Million (2022-2027)
  • Table 108. Pillcam: by Category(USD Million)
  • Table 109. Pillcam Wireless Capsule , by Region USD Million (2022-2027)
  • Table 110. Pillcam Workstation and Receiver , by Region USD Million (2022-2027)
  • Table 111. Pillcam: by Indication(USD Million)
  • Table 112. Pillcam OGIB (Obscure Gastrointestinal Bleeding) , by Region USD Million (2022-2027)
  • Table 113. Pillcam Crohn’s Disease , by Region USD Million (2022-2027)
  • Table 114. Pillcam Small Intestine Tumor , by Region USD Million (2022-2027)
  • Table 115. Pillcam Others (Celiac Disease, NSAID Reactions) , by Region USD Million (2022-2027)
  • Table 116. South America Pillcam, by Country USD Million (2022-2027)
  • Table 117. South America Pillcam, by Type USD Million (2022-2027)
  • Table 118. South America Pillcam, by Category USD Million (2022-2027)
  • Table 119. South America Pillcam, by Indication USD Million (2022-2027)
  • Table 120. Brazil Pillcam, by Type USD Million (2022-2027)
  • Table 121. Brazil Pillcam, by Category USD Million (2022-2027)
  • Table 122. Brazil Pillcam, by Indication USD Million (2022-2027)
  • Table 123. Argentina Pillcam, by Type USD Million (2022-2027)
  • Table 124. Argentina Pillcam, by Category USD Million (2022-2027)
  • Table 125. Argentina Pillcam, by Indication USD Million (2022-2027)
  • Table 126. Rest of South America Pillcam, by Type USD Million (2022-2027)
  • Table 127. Rest of South America Pillcam, by Category USD Million (2022-2027)
  • Table 128. Rest of South America Pillcam, by Indication USD Million (2022-2027)
  • Table 129. Asia Pacific Pillcam, by Country USD Million (2022-2027)
  • Table 130. Asia Pacific Pillcam, by Type USD Million (2022-2027)
  • Table 131. Asia Pacific Pillcam, by Category USD Million (2022-2027)
  • Table 132. Asia Pacific Pillcam, by Indication USD Million (2022-2027)
  • Table 133. China Pillcam, by Type USD Million (2022-2027)
  • Table 134. China Pillcam, by Category USD Million (2022-2027)
  • Table 135. China Pillcam, by Indication USD Million (2022-2027)
  • Table 136. Japan Pillcam, by Type USD Million (2022-2027)
  • Table 137. Japan Pillcam, by Category USD Million (2022-2027)
  • Table 138. Japan Pillcam, by Indication USD Million (2022-2027)
  • Table 139. India Pillcam, by Type USD Million (2022-2027)
  • Table 140. India Pillcam, by Category USD Million (2022-2027)
  • Table 141. India Pillcam, by Indication USD Million (2022-2027)
  • Table 142. South Korea Pillcam, by Type USD Million (2022-2027)
  • Table 143. South Korea Pillcam, by Category USD Million (2022-2027)
  • Table 144. South Korea Pillcam, by Indication USD Million (2022-2027)
  • Table 145. Taiwan Pillcam, by Type USD Million (2022-2027)
  • Table 146. Taiwan Pillcam, by Category USD Million (2022-2027)
  • Table 147. Taiwan Pillcam, by Indication USD Million (2022-2027)
  • Table 148. Australia Pillcam, by Type USD Million (2022-2027)
  • Table 149. Australia Pillcam, by Category USD Million (2022-2027)
  • Table 150. Australia Pillcam, by Indication USD Million (2022-2027)
  • Table 151. Rest of Asia-Pacific Pillcam, by Type USD Million (2022-2027)
  • Table 152. Rest of Asia-Pacific Pillcam, by Category USD Million (2022-2027)
  • Table 153. Rest of Asia-Pacific Pillcam, by Indication USD Million (2022-2027)
  • Table 154. Europe Pillcam, by Country USD Million (2022-2027)
  • Table 155. Europe Pillcam, by Type USD Million (2022-2027)
  • Table 156. Europe Pillcam, by Category USD Million (2022-2027)
  • Table 157. Europe Pillcam, by Indication USD Million (2022-2027)
  • Table 158. Germany Pillcam, by Type USD Million (2022-2027)
  • Table 159. Germany Pillcam, by Category USD Million (2022-2027)
  • Table 160. Germany Pillcam, by Indication USD Million (2022-2027)
  • Table 161. France Pillcam, by Type USD Million (2022-2027)
  • Table 162. France Pillcam, by Category USD Million (2022-2027)
  • Table 163. France Pillcam, by Indication USD Million (2022-2027)
  • Table 164. Italy Pillcam, by Type USD Million (2022-2027)
  • Table 165. Italy Pillcam, by Category USD Million (2022-2027)
  • Table 166. Italy Pillcam, by Indication USD Million (2022-2027)
  • Table 167. United Kingdom Pillcam, by Type USD Million (2022-2027)
  • Table 168. United Kingdom Pillcam, by Category USD Million (2022-2027)
  • Table 169. United Kingdom Pillcam, by Indication USD Million (2022-2027)
  • Table 170. Netherlands Pillcam, by Type USD Million (2022-2027)
  • Table 171. Netherlands Pillcam, by Category USD Million (2022-2027)
  • Table 172. Netherlands Pillcam, by Indication USD Million (2022-2027)
  • Table 173. Rest of Europe Pillcam, by Type USD Million (2022-2027)
  • Table 174. Rest of Europe Pillcam, by Category USD Million (2022-2027)
  • Table 175. Rest of Europe Pillcam, by Indication USD Million (2022-2027)
  • Table 176. MEA Pillcam, by Country USD Million (2022-2027)
  • Table 177. MEA Pillcam, by Type USD Million (2022-2027)
  • Table 178. MEA Pillcam, by Category USD Million (2022-2027)
  • Table 179. MEA Pillcam, by Indication USD Million (2022-2027)
  • Table 180. Middle East Pillcam, by Type USD Million (2022-2027)
  • Table 181. Middle East Pillcam, by Category USD Million (2022-2027)
  • Table 182. Middle East Pillcam, by Indication USD Million (2022-2027)
  • Table 183. Africa Pillcam, by Type USD Million (2022-2027)
  • Table 184. Africa Pillcam, by Category USD Million (2022-2027)
  • Table 185. Africa Pillcam, by Indication USD Million (2022-2027)
  • Table 186. North America Pillcam, by Country USD Million (2022-2027)
  • Table 187. North America Pillcam, by Type USD Million (2022-2027)
  • Table 188. North America Pillcam, by Category USD Million (2022-2027)
  • Table 189. North America Pillcam, by Indication USD Million (2022-2027)
  • Table 190. United States Pillcam, by Type USD Million (2022-2027)
  • Table 191. United States Pillcam, by Category USD Million (2022-2027)
  • Table 192. United States Pillcam, by Indication USD Million (2022-2027)
  • Table 193. Canada Pillcam, by Type USD Million (2022-2027)
  • Table 194. Canada Pillcam, by Category USD Million (2022-2027)
  • Table 195. Canada Pillcam, by Indication USD Million (2022-2027)
  • Table 196. Mexico Pillcam, by Type USD Million (2022-2027)
  • Table 197. Mexico Pillcam, by Category USD Million (2022-2027)
  • Table 198. Mexico Pillcam, by Indication USD Million (2022-2027)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pillcam: by Type USD Million (2016-2021)
  • Figure 5. Global Pillcam: by Category USD Million (2016-2021)
  • Figure 6. Global Pillcam: by Indication USD Million (2016-2021)
  • Figure 7. South America Pillcam Share (%), by Country
  • Figure 8. Asia Pacific Pillcam Share (%), by Country
  • Figure 9. Europe Pillcam Share (%), by Country
  • Figure 10. MEA Pillcam Share (%), by Country
  • Figure 11. North America Pillcam Share (%), by Country
  • Figure 12. Global Pillcam share by Players 2021 (%)
  • Figure 13. Global Pillcam share by Players (Top 3) 2021(%)
  • Figure 14. Global Pillcam share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Olympus Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 17. Olympus Corporation (Japan) Revenue: by Geography 2021
  • Figure 18. IntroMedic Co., Ltd. (South Korea) Revenue, Net Income and Gross profit
  • Figure 19. IntroMedic Co., Ltd. (South Korea) Revenue: by Geography 2021
  • Figure 20. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 21. Medtronic plc (Ireland) Revenue: by Geography 2021
  • Figure 22. Chongqing Jinshan Science & Technology (Group) Co., Ltd (China) Revenue, Net Income and Gross profit
  • Figure 23. Chongqing Jinshan Science & Technology (Group) Co., Ltd (China) Revenue: by Geography 2021
  • Figure 24. Fujifilm Holding Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 25. Fujifilm Holding Corporation (Japan) Revenue: by Geography 2021
  • Figure 26. CapsoVision (United States) Revenue, Net Income and Gross profit
  • Figure 27. CapsoVision (United States) Revenue: by Geography 2021
  • Figure 28. RF System lab (Japan) Revenue, Net Income and Gross profit
  • Figure 29. RF System lab (Japan) Revenue: by Geography 2021
  • Figure 30. Teleflex Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 31. Teleflex Incorporated (United States) Revenue: by Geography 2021
  • Figure 32. Global Pillcam: by Type USD Million (2022-2027)
  • Figure 33. Global Pillcam: by Category USD Million (2022-2027)
  • Figure 34. Global Pillcam: by Indication USD Million (2022-2027)
  • Figure 35. South America Pillcam Share (%), by Country
  • Figure 36. Asia Pacific Pillcam Share (%), by Country
  • Figure 37. Europe Pillcam Share (%), by Country
  • Figure 38. MEA Pillcam Share (%), by Country
  • Figure 39. North America Pillcam Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Olympus Corporation (Japan)
  • IntroMedic Co., Ltd. (South Korea)
  • Medtronic plc (Ireland)
  • Chongqing Jinshan Science & Technology (Group) Co., Ltd (China)
  • Fujifilm Holding Corporation (Japan)
  • CapsoVision (United States)
  • RF System lab (Japan)
  • Teleflex Incorporated (United States)
Select User Access Type

Key Highlights of Report


Jul 2022 208 Pages 89 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pillcam Market Quantitative research analysis
Global Pillcam Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Pillcam Market is heading robustly to achieve a new growth cycle.
The Concentration Rate of Global Pillcam market is dominated by United States & Japanese Players and may generate healthy valuation by 2027.
  • Prevalence of Intestinal Diseases
  • High Investments in Healthcare R&D
dominated the Pillcam market. This is attributable to growing trend of "Rising Geriatric Population"

Know More About Global Pillcam Market Report?

Have a Query? Click Here

Other Related Reports

Muscle Pump Activator Comprehensive Study by Type (Electro-stimulation Device, Wearable Device, Others), End Use (Hospitals, Specialty Clinics, Home Care Setting), Distribution (Hospital Dispensaries...
$ 3450
Telemedicine Equipment Comprehensive Study by Type (Telemedicine Carts, TytoCare, Peripherals, Touchpoint Tablet, Telemedicine Kiosks, Digital Camara, Hospital TV Kit, Mobile Medical Devices, Others)...
$ 3750
Got Test Comprehensive Study by Type (Instruments, Consumables, Others), End Use (Hospitals and Clinics, Diagnostic Laboratories, Others) Players and Region - Global Market Outlook to 2030
$ 3500
Meat Species Identification Kits Comprehensive Study by Type (PCR and Real-Time PCR, Enzyme-Linked Immunosorbent Assay (ELISA)), End Use (Restaurant & Hotels, Food Agencies, Others), Meat (Raw Meat, ...
$ 3500
Radiopharmaceutical Theranostics Comprehensive Study by Type (Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18, Lutetium (Lu) 177, Copper (Cu) 67, Others), Application (Oncology, Cardio...
$ 3650
Health Status Monitoring Comprehensive Study by Type (Blood Glucose Monitoring Systems, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Temperature Monitoring Devices, Others), Category (...
$ 3450